Literature DB >> 32741256

The independent living scale in amnestic mild cognitive impairment: Relationships to demographic variables and cognitive performance.

Kevin Duff1, Sariah Porter1, Ava Dixon1, Kayla Suhrie1, Dustin Hammers1.   

Abstract

INTRODUCTION: The Independent Living Scales (ILS) is an objective measure of day-to-day functioning, which can be used to aid in diagnosing dementia in older adults with cognitive impairments. However, no studies have examined this measure in individuals with Mild Cognitive Impairment (MCI), a prodromal phase of dementia.
METHOD: Therefore, we sought to examine three subscales of the ILS (Managing Money, Managing Home and Transportation, Health and Safety) in a sample of 132 individuals with amnestic MCI, focusing on the relationship of the ILS with demographic variables (age, education, sex) and cognitive abilities (assessed with the Repeatable Battery for the Assessment of Neuropsychological Status [RBANS]).
RESULTS: This MCI sample showed intact daily functioning on the three ILS subscales. In a series of three, separate hierarchical linear regression models, the Managing Money, Managing Home and Transportation, and Health and Safety subscales were all significantly related to demographic variables, and the RBANS Total Scale score significantly added to all models. These models would also allow one to predict an ILS score based on demographic and cognitive data, which could be compared to an observed ILS score to see if it meets expectations.
CONCLUSIONS: Overall, these results indicate that daily functioning, as measured with the ILS, is related to cognitive abilities in amnestic MCI, and that demographic variables also influenced ILS scores in this cohort. Although the ILS may be appropriate for identifying functional abilities in MCI, the consideration of these moderating variables seems necessary.

Entities:  

Keywords:  Mild Cognitive Impairment; daily functioning; demographics; memory

Mesh:

Year:  2020        PMID: 32741256      PMCID: PMC7484154          DOI: 10.1080/13803395.2020.1798884

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  24 in total

1.  Complex real-world functioning and neuropsychological test performance in older adults.

Authors:  A Baird; K Podell; M Lovell; S B McGinty
Journal:  Clin Neuropsychol       Date:  2001-08       Impact factor: 3.535

2.  The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Guy M McKhann; David S Knopman; Howard Chertkow; Bradley T Hyman; Clifford R Jack; Claudia H Kawas; William E Klunk; Walter J Koroshetz; Jennifer J Manly; Richard Mayeux; Richard C Mohs; John C Morris; Martin N Rossor; Philip Scheltens; Maria C Carrillo; Bill Thies; Sandra Weintraub; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

3.  Complex activities of daily living vary by mild cognitive impairment subtype.

Authors:  Katherine J Bangen; Amy J Jak; Dawn M Schiehser; Lisa Delano-Wood; Elizabeth Tuminello; S Duke Han; Dean C Delis; Mark W Bondi
Journal:  J Int Neuropsychol Soc       Date:  2010-04-07       Impact factor: 2.892

4.  Adequate proverb interpretation is associated with performance on the independent living scales.

Authors:  Fayeza S Ahmed; L Stephen Miller
Journal:  Neuropsychol Dev Cogn B Aging Neuropsychol Cogn       Date:  2014-10-14

5.  Short-term practice effects in mild cognitive impairment: Evaluating different methods of change.

Authors:  Kevin Duff; Taylor J Atkinson; Kayla R Suhrie; Bonnie C Allred Dalley; Sydney Y Schaefer; Dustin B Hammers
Journal:  J Clin Exp Neuropsychol       Date:  2016-09-20       Impact factor: 2.475

6.  The relationship between neuropsychological performance and daily functioning in individuals with Alzheimer's disease: ecological validity of neuropsychological tests.

Authors:  Sarah Tomaszewski Farias; Ernest Harrell; Craig Neumann; Andrew Houtz
Journal:  Arch Clin Neuropsychol       Date:  2003-08       Impact factor: 2.813

Review 7.  Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment.

Authors:  B Winblad; K Palmer; M Kivipelto; V Jelic; L Fratiglioni; L-O Wahlund; A Nordberg; L Bäckman; M Albert; O Almkvist; H Arai; H Basun; K Blennow; M de Leon; C DeCarli; T Erkinjuntti; E Giacobini; C Graff; J Hardy; C Jack; A Jorm; K Ritchie; C van Duijn; P Visser; R C Petersen
Journal:  J Intern Med       Date:  2004-09       Impact factor: 8.989

8.  The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity.

Authors:  C Randolph; M C Tierney; E Mohr; T N Chase
Journal:  J Clin Exp Neuropsychol       Date:  1998-06       Impact factor: 2.475

9.  Quantification of five neuropsychological approaches to defining mild cognitive impairment.

Authors:  Amy J Jak; Mark W Bondi; Lisa Delano-Wood; Christina Wierenga; Jody Corey-Bloom; David P Salmon; Dean C Delis
Journal:  Am J Geriatr Psychiatry       Date:  2009-05       Impact factor: 4.105

10.  A survey of neuropsychologists' practices and perspectives regarding the assessment of judgment ability.

Authors:  Laura A Rabin; Marlana J Borgos; Andrew J Saykin
Journal:  Appl Neuropsychol       Date:  2008
View more
  2 in total

1.  Repeatable battery for the assessment of neuropsychological status and its relationship to biomarkers of Alzheimer's disease.

Authors:  Kevin Duff; Kayla R Suhrie; Dustin B Hammers; Ava M Dixon; Jace B King; Vincent Koppelmans; John M Hoffman
Journal:  Clin Neuropsychol       Date:  2021-10-29       Impact factor: 4.373

2.  Efficacy of Corsi Block Tapping Task training for improving visuospatial skills: a non-randomized two-group study.

Authors:  Sydney Y Schaefer; Andrew Hooyman; Nicole K Haikalis; Randy Essikpe; Keith R Lohse; Kevin Duff; Peiyuan Wang
Journal:  Exp Brain Res       Date:  2022-10-13       Impact factor: 2.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.